首页 | 本学科首页   官方微博 | 高级检索  
     

复方半枝莲胶囊抗肿瘤作用的实验研究
引用本文:吴东风 林明宝 舒虹 张进 聂荣庆. 复方半枝莲胶囊抗肿瘤作用的实验研究[J]. 实用中西医结合临床, 2006, 6(6): 79-80
作者姓名:吴东风 林明宝 舒虹 张进 聂荣庆
作者单位:1. 江西省中医药研究院,南昌,330077
2. 南昌大学第一附属医院,南昌,330006
摘    要:目的:观察复方半枝莲胶囊抗肿瘤的作用。方法:采用MTT法观察其对人肝癌细胞、人胃癌细胞的体外抑瘤作用,并观察其对S180及HEPS实体瘤的抑制作用。结果:复方半枝莲胶囊对两种人癌细胞降解MTT半数抑瘤浓度(IC50)分别为1.05mg/mL、1.08mg/mL;体内对S180及HEPS实体瘤有明显的抑制作用,最大抑制率分别为65.31%、49.80%。结论:复方半枝莲胶囊具有明显的抗肿瘤作用。

关 键 词:复方半枝莲胶囊  抗肿瘤作用  实验研究
文章编号:1671-4040(2006)06-0079-02
收稿时间:2006-07-31
修稿时间:2006-07-31

Experimental Study on Anti-tumor Effects of Compound Banzhilian Capsule
Wu Dong-feng,Lin Ming-bao. Experimental Study on Anti-tumor Effects of Compound Banzhilian Capsule[J]. Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine, 2006, 6(6): 79-80
Authors:Wu Dong-feng  Lin Ming-bao
Abstract:Objective:To study the anti-tumor effects of Compound Banzhilian Capsule. Methods:MTT staining to observe Compound Banzhilian Capsule against SMMC-7721 and SGC-7901 cells in vitro. And to observe the inhibitory action against S180 and HEPS tumor in body of Compound Banzhilian Capsule. Results:Determined by MTT staining, the IC50 of Compound Banzhilian Capsule against SMMC-7721, SGC-7901 cells were 1.05, 1.08mg/mL. Determined by inbody anti-tumor experiments, the highest inhibition rate of Compound Banzhilian Capsule against S180, HEPS were 65.31% and 49.80%. Conclusion:Compound Banzhilian Capsule had certainly anti-tumor actions.
Keywords:Compound Banzhilian Capsule  Anti-tumor effects  Experimental study  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《实用中西医结合临床》浏览原始摘要信息
点击此处可从《实用中西医结合临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号